Latest Infectious Disease News
THURSDAY, May 30, 2019 (HealthDay News) -- The first test to detect the Zika virus in human blood has been approved by the U.S. Food and Drug Administration.
Until now, the only FDA-approved tests for Zika were to detect virus antibodies and were only for emergency use.
Zika infection during pregnancy can cause severe birth defects, including abnormally small heads and underdeveloped brains. The mosquito-borne virus can also cause a nervous system disorder called Guillain-Barre syndrome.
In the United States, CDC data show that the majority of the 5,600 cases of Zika in 2016 and 2017 occurred in people who traveled to affected areas, but there were 339 mosquito-born infections in Florida and Texas, CBS News reported.
Copyright © 2019 HealthDay. All rights reserved.